Management of diabetes mellitus complicated with dyslipidemia is a comprehensive task involving lifestyle intervention, pharmacotherapy, regular monitoring, and other aspects. The following recommendations are based on professional guidelines and expert consensus:
I. Lifestyle Intervention
Dietary control is the foundation of managing diabetes with dyslipidemia. A balanced diet with low fat, low sugar, and high fiber is recommended. Fried foods and high-cholesterol items should be avoided, while intake of whole grains, vegetables, and high-quality protein should be increased.Regular exercise is also critical: at least 150 minutes per week of moderate-intensity aerobic exercise combined with resistance training can effectively improve lipid profiles.
II. Pharmacotherapeutic Strategies
For pharmacotherapy, individualized lipid-lowering targets should be established according to the patient’s condition. For diabetic patients, low-density lipoprotein cholesterol (LDL-C) should be controlled within specific ranges.Statins are the first-line lipid-lowering agents suitable for most patients.GLP-1 receptor agonists, such as semaglutide, also exert favorable glucose-lowering and lipid-lowering effects in diabetic patients with obesity or fatty liver disease.Other agents including fibrates and niacin may be chosen based on the lipid profile.
III. Monitoring and Follow-Up
Regular testing and follow-up are essential components of management.Lipids, liver function, and creatine kinase should be rechecked every 3–6 months, along with blood glucose monitoring; glycated hemoglobin (HbA1c) should be controlled within the ideal target range.Annual cardiovascular risk assessment is recommended, including carotid ultrasound and electrocardiography, for early detection of atherosclerosis.
IV. Special Considerations
Several special considerations should be noted during management:
For patients with concomitant hypertension, combined antihypertensive treatment is required to achieve specific blood pressure targets.
For patients with renal insufficiency, drug dosages should be adjusted according to renal function, and drug safety should be closely monitored.Management of diabetes mellitus complicated with dyslipidemia requires individualized treatment plans based on the patient’s specific conditions.Through comprehensive intervention and lifestyle modification, blood lipids and blood glucose can be effectively controlled, thereby reducing the risk of cardiovascular diseases.